Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is intraperitoneal dextran 70 safe for routine gynecologic use?

D M Magyar, M F Hayes, N J Spirtos

    American Journal of Obstetrics and Gynecology
    |May 15, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Conditioned response to fellatio.

    The American journal of psychiatry·2010
    Same author

    Vision screening for frail older people: a randomised trial.

    The British journal of ophthalmology·2008
    Same author

    Hormone replacement therapy for menopausal women.

    Comprehensive therapy·2000
    Same author

    A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.

    Medscape women's health·2000
    Same author

    Medical treatment of endometriosis.

    Clinical obstetrics and gynecology·1999
    Same author

    Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis.

    Fertility and sterility·1998

    Routine use of intraperitoneal 32% dextran 70 in gynecologic surgery is safe and well-tolerated. This antiadhesion regimen effectively prevents pelvic adhesions with minimal side effects in women.

    Area of Science:

    • Gynecology
    • Surgical Adhesion Prevention
    • Pharmacology

    Background:

    • Postsurgical pelvic adhesions are a common complication following gynecologic operations.
    • Intraperitoneal 32% dextran 70 is a potential adjuvant therapy to prevent adhesion formation.

    Purpose of the Study:

    • To evaluate the safety and tolerability of an antiadhesion regimen using intraperitoneal 32% dextran 70, dexamethasone, and promethazine.
    • To assess the efficacy of this regimen in preventing postsurgical pelvic adhesions.

    Main Methods:

    • A prospective study involving 234 women undergoing gynecologic operations.
    • Administration of an antiadhesion regimen including intraperitoneal 32% dextran 70, dexamethasone, and promethazine.

    Main Results:

    Related Experiment Videos

    • Four percent (10/234) of women experienced spontaneous leakage of the dextran-peritoneal fluid mixture.
    • Eight percent (18/234) reported painless bilateral labial swelling.
    • Mild abdominal bloating and weight gain were common; no anaphylactic reactions, peritonitis, or wound infections occurred.

    Conclusions:

    • Intraperitoneal dextran 70, as part of a multi-agent regimen, appears safe and well-tolerated for preventing pelvic adhesions.
    • The observed side effects were generally mild and did not lead to serious complications.
    • This regimen shows promise for routine use in gynecologic surgery to reduce adhesion formation.